胰高血糖素氢氯化物(人)

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 毒理性
  • 结构与计算化学

胰高血糖素氢氯化物(人) 基本信息

中文名称:
胰高血糖素氢氯化物(人) 
中文别名:
胰高血糖素;
胰高血糖素氢氯化物(人) 
英文名称:
Glucagon Hydrochloride (Human)
英文别名:
GLUCAGON HYDROCHLORIDE(HUMAN);
l-histidyl-l-seryl-l-glutaminylglycyl-l-threonyl-l-phenylalanyl-l-l-threonin;
Glucagonoid;
glukagonnovo;
Glukagon;
Glucagon RecoMbinant;
Hyperglycemic-glycogenolytic factor;
HG-Factor 
CAS No.:
9007-92-5
分 子 式:
C153H225N43O49S.HCl
分 子 量:
3519.21
精确分子量:
3516.59000
PSA:
1564.04000
MDL:
MFCD00167532
EINECS:
232-708-2
分子结构式:
SDS:
查看

胰高血糖素氢氯化物(人) 制备方法及用途

制备方法

用于生化研究。医药。

用途简介

用途

三、用途

    用于生化研究。医药。

胰高血糖素氢氯化物(人) 物化性质

熔点:
-15ºC
沸点:
230ºC at 760 mm Hg
存储条件/存储方法:

二、贮存

应充氩气密封于0以下干燥保存。

稳定性相关:

pH2.33.0的水溶液4℃时可保存3个月

其它信息:

1.       性状:白色菱形十二面体细结晶。无气味。无味。

2.       密度(g/mL,20):未确定

3.       相对蒸汽密度(g/mL,空气=1):未确定

4.       熔点(ºC):未确定

5.       沸点(ºC,常压):未确定

6.       沸点(ºC,5.2kPa):未确定

7.       折射率:未确定

8.       闪点(ºC): 未确定

9.       比旋光度(º):未确定

10.    自燃点或引燃温度(ºC):未确定

11.    蒸气压(kPa,20ºC):未确定

12.    饱和蒸气压(kPa,60ºC):未确定

13.    燃烧热(KJ/mol):未确定

14.    临界温度(ºC):未确定

15.    临界压力(KPa):未确定

16.    油水(辛醇/水)分配系数的对数值:未确定

17.    爆炸上限(%,V/V):未确定

18.    爆炸下限(%,V/V):未确定

19.    溶解性:溶于酸性(pH3)、碱性(pH9.5)溶液,几乎不溶于水

胰高血糖素氢氯化物(人) 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LZ3980000
CHEMICAL NAME :
Glucagon
CAS REGISTRY NUMBER :
9007-92-5
LAST UPDATED :
199704
DATA ITEMS CITED :
15
MOLECULAR FORMULA :
C151-H224-N42-O50-S
MOLECULAR WEIGHT :
3460.23

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
140 mg/kg/4W-I
TOXIC EFFECTS :
Liver - changes in liver weight Endocrine - hyperglycemia Blood - changes in erythrocyte (RBC) count
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
140 mg/kg/4W-I
TOXIC EFFECTS :
Liver - changes in liver weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3600 ug/kg
SEX/DURATION :
female 16-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

MUTATION DATA

TYPE OF TEST :
Unscheduled DNA synthesis
TEST SYSTEM :
Rodent - rat Liver
DOSE/DURATION :
75 mg/L
REFERENCE :
EJBCAI European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967- Volume(issue)/page/year: 34,474,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83978 No. of Facilities: 33 (estimated) No. of Industries: 1 No. of Occupations: 4 No. of Employees: 825 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 83978 No. of Facilities: 109 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 11153 (estimated) No. of Female Employees: 9781 (estimated)
毒理学数据:

毒理学数据:

1、急性毒性:大鼠腹腔LD50>200 gm/kg

             大鼠肌肉注射:>200 gm/kg

大鼠静脉注射LD50100 mg/kg

大鼠皮下LD50200 mg/kg

小鼠静脉注射LD50200mg/kg

小鼠肌肉注射LDLo>10 mg/kg

 

其他多剂量毒性数据

大鼠注射LDLo3600 ug/kg

小狗注射LDLo140 gm/kg

繁殖数据

             大鼠皮下LDLo5 gm/kg

胰高血糖素氢氯化物(人) 分子结构与计算化学数据

计算化学数据

1.疏水参数计算参考值(XlogP):-16.9

2.氢键供体数量:55

3.氢键受体数量:55

4.可旋转化学键数量:115

5.互变异构体数量:1000

6.拓扑分子极性表面积1560

7.重原子数量:246

8.表面电荷:0

9.复杂度:8160

10.同位素原子数量:0

11.确定原子立构中心数量:31

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>

湖北云镁科技有限公司

产品介绍:
产品名称:胰高血糖素氢氯化物(人) Cas号:9007-92-5 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶 价格:1.0元 - 25.0元
联系方式:
联系人:方经理 电话:027-59206672 手机:18327059871

上海吉至生化科技有限公司

产品介绍:
产品名称:胰高血糖素 Cas号:9007-92-5 纯度:97% 包装信息:1mgea 价格:2,808.0元
联系方式:
联系人:江珊 电话:021-57520831 手机:15316869680

上海楚肽生物科技有限公司

产品介绍:
产品名称:GLUCAGON HYDROCHLORIDE(HUMAN) Cas号:9007-92-5 纯度:98% 包装信息:1kg,1g,100mg,5mg 价格:洽谈
联系方式:
联系人:吴经理 电话:021-50673982 手机:17321195801